Alectos Therapeutics
PrivateLast Round
Strategic
Jun 6, 2022
Total Funding Raised
$15M
Company Overview
Alectos Therapeutics operates in Healthcare & Life Sciences and is based in Burnaby. Its latest recorded funding round was a Strategic round in June 2022.
Alectos Therapeutics is a biotechnology company that discovers and develops novel small-molecule therapeutics for neurodegenerative and acute neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alectos Therapeutics Comparables
Compare Alectos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asceneuron | 87% | |
| Gain Therapeutics Inc | 77% | |
| Vanqua Bio | 76% |
For institutional investors. Book with your work email.
Alectos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 6, 2022 | ||||
| Strategic | Aug 11, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 770% MoM to 2.4K.
- Jul 21, 2025
Grew 23% QoQ, from 13 to 16 employees.
For institutional investors. Book with your work email.
Alectos Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alectos Therapeutics's valuation, stock price, and market status.
Is Alectos Therapeutics a public or private company?
Alectos Therapeutics is a private company.
What is the current stock price of Alectos Therapeutics?
Alectos Therapeutics is a private company, so its shares have no public market price. Caplight tracks Alectos Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alectos Therapeutics worth (valuation)?
Valuation information for Alectos Therapeutics is not publicly available.
Can I buy Alectos Therapeutics stock?
Alectos Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alectos Therapeutics's last funding round?
Alectos Therapeutics's most recent funding round was Strategic on June 6, 2022.
Who are the main investors in Alectos Therapeutics?
Investor information for Alectos Therapeutics is not publicly disclosed.
Will Alectos Therapeutics IPO soon?
No public IPO plans have been announced for Alectos Therapeutics.
How can I track Alectos Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Alectos Therapeutics's shares on secondary markets.